Kura Oncology Cash from Financing (TTM) Analysis

Kura Oncology Inc (KURA)

20.31 -0.28 (-1.34%) USD | NASDAQ | May 03, 11:48

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2015. Upgrade now.

Date	Value
December 31, 2023	94.78M
September 30, 2023	128.80M
June 30, 2023	129.60M
March 31, 2023	38.26M
December 31, 2022	38.56M
September 30, 2022	4.646M
June 30, 2022	6.024M
March 31, 2022	-3.211M
December 31, 2021	-3.435M
September 30, 2021	322.81M
June 30, 2021	325.23M
March 31, 2021	469.17M
December 31, 2020	469.33M
September 30, 2020	142.88M
June 30, 2020	138.76M
March 31, 2020	111.25M
December 31, 2019	111.10M

Date	Value
September 30, 2019	111.66M
June 30, 2019	185.08M
March 31, 2019	75.09M
December 31, 2018	132.64M
September 30, 2018	131.16M
June 30, 2018	110.90M
March 31, 2018	111.21M
December 31, 2017	53.57M
September 30, 2017	53.90M
June 30, 2017	0.194M
March 31, 2017	7.458M
December 31, 2016	7.453M
September 30, 2016	57.73M
June 30, 2016	57.48M
March 31, 2016	46.29M
December 31, 2015	102.87M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-3.435M

Minimum

Dec 2021

469.33M

Maximum

Dec 2020

148.49M

Average

111.66M

Median

Sep 2019

Cash from Financing (TTM) Benchmarks